Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon

NCT02583789 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Raynaud's Phenomenon

Interventions

DRUG: oral treprostinil
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]